Global Cannabis·Since 2013
Unleashing the power of cannabis to improve lives.
Canopy Growth is a leading global cannabis company — showcasing the capacity of cannabis as a force for good, from personal wellness to economic opportunity and social justice.
Smiths Falls, Ontario
Who we are
Canopy is a global, best-in-class cannabis and CPG company — demonstrating the ability of cannabis as a positive agent for change.
Personal wellness
High-quality products with best-in-class cannabinoid effects, for every moment in the day.
Economic opportunity
Building a world-class CPG company and a new model for a transformational industry.
Social justice
Leading with purpose, and demonstrating how cannabis can be a catalyst for positive change.
Canopy USA
Fast-tracking entry into the world's largest cannabis market.
Canopy Growth has announced plans to fast-track entry into the United States cannabis market and capitalize on this once-in-a-generation opportunity — built with intention and defined by purpose.
US$50B
Projected size of the U.S. retail cannabis market in 2026 — a once-in-a-generation opportunity Canopy is positioned to capture.
Products
Cannabis for every consumer.
We unlock the properties of cannabis to improve lives, offering high-quality products with best-in-class cannabinoid effects. Rooted in a belief that every moment in the day can be enhanced, we are redefining experiences with cannabis and demonstrating the true potential of this powerful plant.
Quality
From seed to experience, crafted with intention.
Best-in-class insights guide every innovation — so each product delivers the quality and cannabinoid effects consumers trust.
Portfolio
A portfolio of brands consumers love.
Momentum
Built for sustained, long-term growth.
+27%
Q4 FY26 net revenue growth, Canada Medical
+68%
Q4 FY26 growth, International Markets Cannabis
$131.3M
Net cash at fiscal year-end 2026
TSX: WEED · Nasdaq: CGC
Newsroom
Latest from Canopy.
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Q4 net revenue grew 27% in Canada Medical and 68% in International Markets Cannabis. The Company closed fiscal 2026 with $131.3M of net cash and reiterated its path to positive Adjusted EBITDA in fiscal 2027.
Read release →Claybourne's Frosted Flyers Wins 'Best Infused Pre-Roll' at 2026 Grow Up Awards
Claybourne extends its market-share momentum with an expanded Frosted Flyers lineup — new variety formats built for flavour, discovery and summer pre-roll season.
Read release →Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup
First international release following the MTL acquisition. Pablo's Revenge, Dante'z Inferno and Frost'd Flakes launch under Tweed, targeting rapid growth in Germany's medical cannabis market.
Read release →Careers
Help us unleash the power of cannabis to improve lives.
We're always searching for exceptional talent dedicated to making a positive impact on the world.